Susan Vogel

1.8k total citations
15 papers, 1.3k citations indexed

About

Susan Vogel is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Susan Vogel has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Virology, 9 papers in Infectious Diseases and 7 papers in Epidemiology. Recurrent topics in Susan Vogel's work include HIV Research and Treatment (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers) and HIV/AIDS drug development and treatment (6 papers). Susan Vogel is often cited by papers focused on HIV Research and Treatment (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers) and HIV/AIDS drug development and treatment (6 papers). Susan Vogel collaborates with scholars based in United States and Canada. Susan Vogel's co-authors include Richard T. Davey, Michael A. Polis, Joseph A. Kovacs, Henry Masur, Robert Walker, Judith Falloon, Julia A. Metcalf, Robin Dewar, Michael Baseler and Randy Stevens and has published in prestigious journals such as New England Journal of Medicine, Journal of Virology and Kidney International.

In The Last Decade

Susan Vogel

14 papers receiving 1.2k citations

Peers

Susan Vogel
Rachid Agher France
Arumugam Balamurugan United States
Srini Ramanathan United States
Rhonda Holdsworth Australia
T Koshiba Japan
Sanit Makonkawkeyoon Thailand
Nimerta Rajwans Canada
John F. Sullivan United States
Kaneo Yamada Japan
R Duquesnoy United States
Rachid Agher France
Susan Vogel
Citations per year, relative to Susan Vogel Susan Vogel (= 1×) peers Rachid Agher

Countries citing papers authored by Susan Vogel

Since Specialization
Citations

This map shows the geographic impact of Susan Vogel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Vogel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Vogel more than expected).

Fields of papers citing papers by Susan Vogel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Vogel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Vogel. The network helps show where Susan Vogel may publish in the future.

Co-authorship network of co-authors of Susan Vogel

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Vogel. A scholar is included among the top collaborators of Susan Vogel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Vogel. Susan Vogel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Tilton, John C., Alison J. Johnson, Bader Yassine‐Diab, et al.. (2003). Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2. Journal of Virology. 77(20). 10900–10909. 148 indexed citations
2.
Kovacs, Joseph A., Susan Vogel, Randy Stevens, et al.. (2001). Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy. European Journal of Immunology. 31(5). 1351–1360. 48 indexed citations
3.
Kovacs, Joseph A., Hiromi Imamichi, Susan Vogel, et al.. (2000). Effects of Intermittent Interleukin‐2 Therapy on Plasma and Tissue Human Immunodeficiency Virus Levels and Quasi‐Species Expression. The Journal of Infectious Diseases. 182(4). 1063–1069. 25 indexed citations
4.
Besarab, Anatole, Neeta B. Amin, Muhammad Ahsan, et al.. (2000). Optimization of Epoetin Therapy with Intravenous Iron Therapy in Hemodialysis Patients. Journal of the American Society of Nephrology. 11(3). 530–538. 210 indexed citations
5.
Hatano, Hiroyu, Susan Vogel, Christian Yoder, et al.. (2000). Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression. AIDS. 14(10). 1357–1363. 79 indexed citations
6.
Vogel, Susan. (2000). Benefits of early utilization of intravenous iron.. PubMed. 27(1). 61–5. 1 indexed citations
7.
Gupta, Ajay, Neeta B. Amin, Anatole Besarab, et al.. (1999). Dialysate iron therapy: Infusion of soluble ferric pyrophosphate via the dialysate during hemodialysis. Kidney International. 55(5). 1891–1898. 45 indexed citations
8.
Piscitelli, Stephen C., Alan Forrest, Susan Vogel, et al.. (1998). Pharmacokinetic modeling of recombinant interleukin-2 in patients with human immunodeficiency virus infection. Clinical Pharmacology & Therapeutics. 64(5). 492–498. 11 indexed citations
9.
Piscitelli, Stephen C., Susan Vogel, William D. Figg, et al.. (1998). Alteration in Indinavir Clearance During Interleukin‐2 Infusions in Patients Infected with the Human Immunodeficiency Virus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 18(6). 1212–1216. 21 indexed citations
10.
Vogel, Susan, et al.. (1997). Supportive care during aldesleukin therapy for patients infected with human immunodeficiency virus. American Journal of Health-System Pharmacy. 54(10). 1191–1193. 2 indexed citations
11.
Kovacs, Joseph A., Susan Vogel, Jeffrey M. Albert, et al.. (1996). Controlled Trial of Interleukin-2 Infusions in Patients Infected with the Human Immunodeficiency Virus. New England Journal of Medicine. 335(18). 1350–1356. 320 indexed citations
12.
Vogel, Susan, et al.. (1996). APPLICATION OF LABORATORY DIAGNOSTICS IN HIV NURSING. Nursing Clinics of North America. 31(1). 41–56.
13.
Kovacs, Joseph A., Michael Baseler, Robin Dewar, et al.. (1995). Increases in CD4 T Lymphocytes with Intermittent Courses of Interleukin-2 in Patients with Human Immunodeficiency Virus Infection — A Preliminary Study. New England Journal of Medicine. 332(9). 567–575. 336 indexed citations
14.
Powell, Frank C., Thomas H. Shawker, A Premkumar, et al.. (1994). Symptomatic interleukin-2-induced cholecystopathy in patients with HIV infection.. American Journal of Roentgenology. 163(1). 117–121. 7 indexed citations
15.
Schnittman, Steven, et al.. (1994). A Phase I Study of Interferon-α2b in Combination with Interleukin-2 in Patients with Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 169(5). 981–989. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachid Agher Breakdown of academic impact, for papers by Arumugam Balamurugan Breakdown of academic impact, for papers by Srini Ramanathan Breakdown of academic impact, for papers by Rhonda Holdsworth Breakdown of academic impact, for papers by T Koshiba Breakdown of academic impact, for papers by Sanit Makonkawkeyoon Breakdown of academic impact, for papers by Nimerta Rajwans Breakdown of academic impact, for papers by John F. Sullivan Breakdown of academic impact, for papers by Kaneo Yamada Breakdown of academic impact, for papers by R Duquesnoy
Rankless by CCL
2026